Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.
Jessica L. Kerr, PharmD, CDE
Advertisement
Articles by Jessica L. Kerr, PharmD, CDE
This Continuing Education activity is supported by an educational grant from Novo Nordisk.
Advertisement
Latest Updated Articles
Pharmacists Reaching Out in Diabetes: Optimizing Insulin Therapy Through Patient Engagement and ManagementPublished: April 18th 2016 | Updated:
Sodium-Glucose Co-Transporter-2 Inhibitors: An Update on the Evidence for Treatment of Type 2 DiabetesPublished: October 13th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Advanced Wearable Accelerometer Shows Promise in Detecting Functional Capacity and Outcomes in Heart Failure Patients
2
Major Review Finds No Link Between Maternal Tylenol and Autism Spectrum Disorder, ADHD
3
Opinion: Pharmacists Are Critical to Ensure Safe, Ethical Integration of AI in Health Care
4
FDA Removes Black Boxed Warning From Hormone Therapies for Menopause
5
